Sucampo Pharma (SCMP) Posts Wider than Expected Q4 loss
Tweet Send to a FriendGet Alerts SCMP Hot Sheet
Price: $9.46 +0.42%
EPS Growth %: +433.3%
Financial Fact:
Selling and marketing: 5.39M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +433.3%
Financial Fact:
Selling and marketing: 5.39M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade SCMP Now!
Sucampo Pharmaceuticals (NASDAQ: SCMP) reported Q4 loss of $0.15, $0.14 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $15.5 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
